Clinical Trial Update: ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease [NA]

View source ↗

Summary

The clinical trial evaluating ExAblate Transcranial MR-guided focused ultrasound targeting the subthalamic nucleus for Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ExAblate Transcranial MRgFUS - Subthalamic Nucleus

Snippet

Sponsor: InSightec | Conditions: Parkinson's Disease | NA | Status: COMPLETED